Consolidated Balance Sheet

Delta-Fly Pharma, Inc. - Filing #7713831

Concept As at
2018-12-31
As at
2018-03-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
Property, plant and equipment
Property, plant and equipment
31,606,000 JPY
30,898,000 JPY
Intangible assets
Intangible assets
93,000 JPY
120,000 JPY
Investments and other assets
2,865,000 JPY
1,418,000 JPY
Investments and other assets
Non-current assets
34,565,000 JPY
32,436,000 JPY
Current assets
Cash and deposits
3,655,264,000 JPY
781,250,000 JPY
Other
31,466,000 JPY
50,457,000 JPY
Current assets
3,686,730,000 JPY
831,708,000 JPY
Assets
3,721,295,000 JPY
864,145,000 JPY
Liabilities and net assets
Non-current liabilities
7,964,000 JPY
13,058,000 JPY
Long-term borrowings
7,964,000 JPY
13,058,000 JPY
Current liabilities
38,996,000 JPY
28,593,000 JPY
Accounts payable - other
15,362,000 JPY
18,200,000 JPY
Liabilities
46,960,000 JPY
41,651,000 JPY
Shareholders' equity
3,674,335,000 JPY
822,493,000 JPY
Share capital
2,795,185,000 JPY
1,117,500,000 JPY
Capital surplus
2,775,185,000 JPY
1,097,500,000 JPY
Retained earnings
-1,896,035,000 JPY
-1,392,506,000 JPY
Net assets
3,674,335,000 JPY
822,493,000 JPY
Liabilities and net assets
3,721,295,000 JPY
864,145,000 JPY
Liabilities
Non-current liabilities
Current liabilities
Current portion of long-term borrowings
6,792,000 JPY
6,792,000 JPY
Income taxes payable
15,792,000 JPY
2,224,000 JPY
Other
1,049,000 JPY
1,376,000 JPY
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.